Inventiva S.A.
ENXTPAInventiva heads into its June 30 results update with a stock down 28% in a month, a short score climbing sharply, and borrowing costs that have more than doubled since April — a combination that puts the French clinical-stage biotech firmly in focus this week. The most striking development is the trajectory of the ORTEX short score, which has risen from 51.1 on May 29 to 56.0…
Snapshot as of 11 Jun 2026
Inventiva heads into its June 30 results update with a stock down 28% in a month, a short score climbing sharply, and borrowing costs that have more than doubled since April — a combination that puts the French…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IVA — free to start on ORTEX.
Sign up for free →Open IVA on ORTEX